Controlled formation of polylysinized inner pores in injectable microspheres of low molecular weight poly(lactide-co-glycolide) designed for efficient loading of therapeutic cells
Source abstract
Abstract
This study aimed to develop porous microspheres with a suitable porous structure and mechanical property for cell delivery using a comparatively low molecular weight (MW) poly(lactide-co-glycolide) (PLGA) having a weak mechanical strength and fast degradation rate, which could be potentially used for treatment of corneal endothelial diseases. Porous microspheres of 30 kDa PLGA with different pore sizes were prepared by varying preparation conditions, and the microspheres with mean pore diameters approximately 0.5, 1, 2 and 3 times that of a single green fluorescent protein-expressing human embryonic kidney 293 cell, used as a model cell, were chosen for cell loading study. The microspheres with an average pore diameter two times greater than that of the single cell were found to be the most appropriate for efficient cell loading in the inner pore spaces, along with demonstrating a good mechanical property, injectability and biodegradability. To maximize the cell loading amount in the microspheres, the cell adhesive property of the microspheres and cell loading conditions were optimized, leading to approximately 4.2 times increase in the cell loading amount. The porous microspheres designed using the low MW PLGA hold promise as a delivery system of corneal endothelial cells for regeneration of the corneal endothelium.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Corneal Surgery and Treatments · Advanced Drug Delivery Systems · Ocular Surface and Contact Lens
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Pharmacy, Chung-Ang University
Department of Ophthalmology, Hallym University College of Medicine
Funding
National Research Foundation of Korea
References (34)
Show source-provided references
1. 10.1016/j.jconrel.2015.01.00410.1016/j.jconrel.2015.01.004 ↗
2. 10.1089/ten.tea.2013.049810.1089/ten.tea.2013.0498 ↗
3. 10.1016/j.actbio.2013.12.00610.1016/j.actbio.2013.12.006 ↗
4. 10.4012/dmj.2011-05510.4012/dmj.2011-055 ↗
5. 10.1016/j.actbio.2013.09.00210.1016/j.actbio.2013.09.002 ↗
6. 10.1021/acsomega.6b0049510.1021/acsomega.6b00495 ↗
7. 10.1016/j.actbio.2014.08.01510.1016/j.actbio.2014.08.015 ↗
8. Newsholme EA, Leech AR. Functional biochemistry in health and disease. Chichester, West Sussex: Wiley-Blackwell; 2009.
9. 10.1016/j.ceramint.2014.04.10010.1016/j.ceramint.2014.04.100 ↗
10. 10.1080/17425247.2016.122929810.1080/17425247.2016.1229298 ↗
11. 10.1167/iovs.03-117410.1167/iovs.03-1174 ↗
12. 10.1136/bjo.2004.05059110.1136/bjo.2004.050591 ↗
13. 10.1167/iovs.05-046210.1167/iovs.05-0462 ↗
14. 10.1016/j.jecm.2013.02.00110.1016/j.jecm.2013.02.001 ↗
15. 10.3390/polym303137710.3390/polym3031377 ↗
16. 10.1002/jbm.a.3550510.1002/jbm.a.35505 ↗
17. 10.1016/j.biomaterials.2006.07.03910.1016/j.biomaterials.2006.07.039 ↗
18. 10.1155/2011/41274310.1155/2011/412743 ↗
19. 10.1016/j.biomaterials.2005.05.08110.1016/j.biomaterials.2005.05.081 ↗
20. 10.1038/nprot.2009.15610.1038/nprot.2009.156 ↗
21. 10.1208/s12249-011-9625-y10.1208/s12249-011-9625-y ↗
22. 10.1089/jop.2007.011310.1089/jop.2007.0113 ↗
23. 10.1039/c0ay00116c10.1039/c0ay00116c ↗
24. 10.1016/j.actbio.2009.04.01210.1016/j.actbio.2009.04.012 ↗
25. 10.1007/BF0298003710.1007/BF02980037 ↗
26. 10.1002/pat.62910.1002/pat.629 ↗
27. 10.1021/la904606610.1021/la9046066 ↗
28. 10.1073/pnas.160843811310.1073/pnas.1608438113 ↗
29. Sterile hypodermic syringes for single use — Part 1: syringes for manual use. The International Organization for Standardization ISO 7886-1. Geneva Switzerland; 2017.
30. 10.1016/j.bbamem.2006.09.01510.1016/j.bbamem.2006.09.015 ↗
31. 10.1016/j.carbon.2014.12.03510.1016/j.carbon.2014.12.035 ↗
32. 10.3390/polym703055210.3390/polym7030552 ↗
33. 10.1007/s10867-008-9108-x10.1007/s10867-008-9108-x ↗
34. 10.1002/term.184210.1002/term.1842 ↗